AME.NYSEAmetek Inc/

Form 4: AMETEK Executive Thomas C. Marecic Reports Stock and Option Transactions

Sentiment:

SEC Form 4 Filing


Thomas C. Marecic, a top executive at AMETEK, reported the acquisition of restricted stock and stock options, along with adjustments to his holdings of common stock.

Summary

  • On March 19, 2024, Thomas C. Marecic, President of Electronic Instruments at AMETEK Inc., reported transactions involving AMETEK's securities.
  • Marecic acquired 1,280 shares of common stock at a price of $181.93 per share.
  • He also acquired 3,880 stock options with an exercise price of $181.93, which will vest in three equal annual installments starting March 19, 2025.
  • Following these transactions, Marecic directly owns 39,770 shares of common stock.
  • He also has indirect ownership through his wife (348 shares) and 401k plans (3,010 shares and 13,467 shares).
  • Marecic directly owns 3,880 stock options.

Sentiment

Score: 6

Explanation: Neutral sentiment. This is a standard regulatory filing detailing stock transactions. The acquisition of shares and options could be seen as a positive sign, but it's a routine occurrence.

Positives

  • The acquisition of restricted stock and stock options suggests confidence in AMETEK's future performance.

Future Outlook

The stock options will become exercisable in three equal annual installments beginning on March 19, 2025.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Comparison to Industry Standards

  • Executive compensation packages often include stock options and restricted stock to align management's interests with those of shareholders.
  • The vesting schedule of the options (three equal annual installments) is a common practice.
  • Comparing the size of the option grant to those of executives at peer companies (e.g., Danaher, Fortive) would provide further context.

Stakeholder Impact

  • The transactions could have a minor positive impact on shareholder sentiment, as they indicate management's belief in the company's future prospects.

Key Dates

DateDescription
03/19/2024Date of the reported transactions: acquisition of common stock and stock options.
03/19/2025First vesting date for the stock options, with equal annual installments thereafter.
03/20/2024Date of signature of the report.
03/19/2034Expiration date of the stock options.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.